This article is more than 5 years old. Information may no longer be current.

VIDEO: Wet AMD gene therapy trial shows optimistic results

Issue: June 10, 2019

ByAllen C. Ho, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

VANCOUVER, British Columbia —Allen C. Ho, MD, of Wills Eye Hospital discusses phase 1/2 data from a clinical trial of a gene therapy treatment candidate for wet age-related macular degeneration at the Association for Research in Vision and Ophthalmology meeting.

The single-dose NAV AAV8 treatment has shown safety in all cohorts and a promising reduction in the need for rescue injections in its third cohort, Ho said.